Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Covaxin Phase 3 Efficacy Study
NCT04641481Phase 3Unknown
- Sponsor
- Bharat Biotech
- Start
- Nov 2020
- Primary completion
- Jan 2021
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Covaxin with Placebo (2 arms). Primary endpoint: First occurrence of Virologically confirmed (RT-PCR positive) symptomatic cases of COVID-19. Status: unknown.
02
Drugs
COVAXIN
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04641481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04641481.